Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Short term Debt (2020 - 2025)

MDxHealth (MDXH) has disclosed Short term Debt for 6 consecutive years, with $2.1 million as the latest value for Q4 2025.

  • Quarterly Short term Debt rose 548.15% to $2.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.1 million through Dec 2025, up 548.15% year-over-year, with the annual reading at $2.1 million for FY2025, 548.15% up from the prior year.
  • Short term Debt hit $2.1 million in Q4 2025 for MDxHealth, up from $324000.0 in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $4.4 million in Q4 2021 to a low of $324000.0 in Q4 2024.
  • Historically, Short term Debt has averaged $2.0 million across 5 years, with a median of $2.1 million in 2025.
  • Biggest five-year swings in Short term Debt: plummeted 72.37% in 2023 and later skyrocketed 548.15% in 2025.
  • Year by year, Short term Debt stood at $4.4 million in 2021, then tumbled by 47.6% to $2.3 million in 2022, then plummeted by 72.37% to $643000.0 in 2023, then tumbled by 49.61% to $324000.0 in 2024, then surged by 548.15% to $2.1 million in 2025.
  • Business Quant data shows Short term Debt for MDXH at $2.1 million in Q4 2025, $324000.0 in Q4 2024, and $643000.0 in Q4 2023.